A previously unknown protein in a family of bacteria found in soil and the human gut microbiome has been discovered—which ...

The discovery sheds light on how certain bacteria -- including strains that cause food poisoning and anthrax -- form spores for survival.

Researchers discovered lariocidin, a lasso peptide antibiotic that kills multidrug-resistant bacteria by binding a novel ...

EDEN identifies B cell antigens that share features with known highly protective proteins and have potential to trigger a robust and protective immune response against almost any bacterial ...

Antibodies are special proteins that lock on to specific antigens. Each B cell makes one specific antibody. For instance, one might make an antibody against the bacteria that cause pneumonia ...

The method triggers immune responses that inhibit melanoma, triple-negative breast cancer, lung carcinoma, and ovarian cancer ...

coli (UPEC). The mRNA vaccine targets the fimH antigen, an adhesive surface protein that helps the bacteria colonize the bladder and kidney. UPEC is responsible for 70-90% of recurrent UTIs ...

The effects Pulendran’s team found appeared to be mediated by Toll-like receptor 5 (TLR5), a molecule that mediates an immune reaction to flagellin, the protein which forms filamentous bacterial ...

Their vaccine avoids the need to hunt down a specific tumor antigen, instead relying on a digested mix of protein fragments ... infectious diseases caused by bacteria or viruses, cancer vaccines ...

In a study published in Cell, researchers from Osaka University have revealed that the body's own proteins with an unusual ... The paper is titled "Neoself-antigens are the primary target for ...

Here the authors display antigen and ... multidrug-resistant bacteria and treating mice with acute intestinal infection. Proline plays an important role in mediating protein folding and stability ...

Researchers have identified a previously unknown bacterial protein, the structure of which is being used in the design of protein nanoparticles for the targeted delivery of anticancer drugs to tumors.